Search research articles
Contact Us
Filters
Showing results (161-170 of 186) with videos related to
Page
of 19
Sort By:
Communications Biology
|
October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis
Belamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Nature Communications
|
November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35
Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Science Advances
|
March 3, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma
Jordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.
Cancers
|
April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma
Laura D Gamble, Stefania Purgato, Michelle J Henderson, et al.
Science Translational Medicine
|
February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma
Laura D Gamble, Stefania Purgato, Jayne Murray, et al.
Cancer Research
|
July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
Chelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2021
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Lin Xiao, Klaartje Somers, Jayne Murray, et al.
Nature Communications
|
December 12, 2024
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma
Jourdin R C Rouaen, Antonietta Salerno, Tyler Shai-Hee, et al.
Science Translational Medicine
|
November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R Carter, Jayne Murray, Belamy B Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 186) with videos related to
Sort By:
Page
of 19
Communications Biology
|
October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis
Belamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Nature Communications
|
November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35
Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Science Advances
|
March 3, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma
Jordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.
Cancers
|
April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma
Laura D Gamble, Stefania Purgato, Michelle J Henderson, et al.
Science Translational Medicine
|
February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma
Laura D Gamble, Stefania Purgato, Jayne Murray, et al.
Cancer Research
|
July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
Chelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2021
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Lin Xiao, Klaartje Somers, Jayne Murray, et al.
Nature Communications
|
December 12, 2024
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma
Jourdin R C Rouaen, Antonietta Salerno, Tyler Shai-Hee, et al.
Science Translational Medicine
|
November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R Carter, Jayne Murray, Belamy B Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Page
of 19